NDC 80425-0320-01 - Escitalopram
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0320
- Requested NDC
- 80425-0320-01
- Package NDCs from labels
- 80425-0320-1, 80425-0320-2, 80425-0320-3, 80425-0320-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Escitalopram - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0320-1 | Escitalopram | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 80425-0320-2 | Escitalopram | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 | |
| 80425-0320-3 | Escitalopram | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0320 | ESCITALOPRAM TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f914fec5-4ce7-794d-e053-6294a90a7cc5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0320-1 | EA - Each | 80425-0320 | 46dcd70d-fdea-4981-8764-ddbaaccae7cc | 1 | 2023-06-06 |
| 80425-0320-2 | EA - Each | 80425-0320 | 7cff7ce0-3352-459a-b266-2a305e782f8f | 1 | 2023-06-06 |
| 80425-0320-3 | EA - Each | 80425-0320 | 0b8ccf87-87c4-429f-9b0d-52dba9ec86d6 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Escitalopram | ESCITALOPRAM | Bryant Ranch Prepack | 102c3893-4fdc-40b3-bd83-775e292723d7 | 2024-08-23 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | Bryant Ranch Prepack | c842ec12-8792-47a9-82ad-9edf99e549ba | 2024-08-23 | Boxed warning, Warnings, Adverse reactions | ANDA078032 349332 5U85DBW7LO |
| Escitalopram Oxalate | ESCITALOPRAM OXALATE | A-S Medication Solutions | 76993020-6715-4090-847e-0fdcc5328f31 | 2024-07-31 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram Oxalate | ESCITALOPRAM OXALATE | A-S Medication Solutions | c980262b-31f0-46df-902d-e593e1557fef | 2024-07-31 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | NuCare Pharmaceuticals, Inc. | 4a645652-ae1f-3811-e054-00144ff8d46c | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | NuCare Pharmaceuticals,Inc. | a489600b-6ae0-edb7-e053-2a95a90a7d00 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Escitalopram Oxalate | ESCITALOPRAM OXALATE | NorthStar RxLLC | 81840aec-96fd-4af2-bd10-3f38d068f39a | 2024-07-05 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram oxalate | ESCITALOPRAM | Exelan Pharmaceuticals Inc. | 8a3f4bc9-cd6e-49b1-ab6c-982b70f51fd2 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | NuCare Pharmaceuticals,Inc. | 8e88bc86-d5e2-50ca-e053-2995a90a0f0e | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| escitalopram | ESCITALOPRAM | Macleods Pharmaceuticals Limited | 4d5c3142-b850-49b9-9f5c-81fe15ea7bfb | 2024-05-24 | Boxed warning, Warnings, Adverse reactions | 5U85DBW7LO |
| Escitalopram Oxalate | ESCITALOPRAM OXALATE | Macleods Pharmaceuticals Limited | 24b43cb4-1a26-44a2-b1d8-a40239eb5c7c | 2024-05-22 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | A-S Medication Solutions | b85ef018-0217-4ddf-885d-206acc0a5f84 | 2024-04-30 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | A-S Medication Solutions | 2ffc6ec3-830f-46bc-9b3f-7c42cefa39b2 | 2024-04-25 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | Advanced Rx Pharmacy of Tennessee, LLC | 138f8703-2f13-6d07-e063-6394a90a4413 | 2024-03-19 | Boxed warning, Warnings, Adverse reactions | 349332 5U85DBW7LO |
| Escitalopram | ESCITSLOPRAM | Lupin Pharmaceuticals, Inc. | 41f7392a-1f5c-4542-9c5c-f9e109851381 | 2023-12-18 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | A-S Medication Solutions | 575d7755-0518-4d48-bb1a-4ad01321fde7 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351250 5U85DBW7LO |
| Lexapro | ESCITALOPRAM | Allergan, Inc. | 13bb8267-1cab-43e5-acae-55a4d957630a | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 351249 351250 349332 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM | A-S Medication Solutions | 9b0b3c54-5bbc-4db9-9c69-00dac1347f24 | 2023-07-24 | Boxed warning, Warnings, Adverse reactions | ANDA078032 351249 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | NCS HealthCare of KY, LLC dba Vangard Labs | ac9ede0c-7912-4e7d-83b3-964feee61215 | 2023-07-20 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
| Escitalopram | ESCITALOPRAM OXALATE | A-S Medication Solutions | 10b25a10-c5e7-479b-a9f5-7eeafd802323 | 2023-04-16 | Boxed warning, Warnings, Adverse reactions | 351250 5U85DBW7LO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.